Management of Type 2 Diabetes Mellitus in Pregnancy
Insulin is the preferred agent for management of type 2 diabetes mellitus during pregnancy, as it does not cross the placenta to a measurable extent and has the strongest safety profile for both mother and fetus. 1, 2
First-Line Treatment Approach
- Insulin therapy should be initiated or continued as the primary treatment for T2DM in pregnancy
- Both multiple daily injections and insulin pump therapy are appropriate delivery methods 2
- Insulin requirements typically increase significantly during the second and third trimesters due to increasing insulin resistance
- Higher doses may be needed compared to type 1 diabetes, sometimes requiring concentrated insulin formulations 1, 2
Glycemic Targets
- Strict glycemic control is essential to reduce maternal and fetal complications:
- Fasting: 70-95 mg/dL
- 1-hour postprandial: 110-140 mg/dL
- 2-hour postprandial: 100-120 mg/dL
- A1C target <6% if achievable without significant hypoglycemia 2
Lifestyle Management
- Medical nutrition therapy with an individualized meal plan developed by a registered dietitian
- Weight gain recommendations:
- Regular physical activity as tolerated and appropriate for pregnancy
Special Considerations and Monitoring
Hypoglycemia risk: Women have increased risk of hypoglycemia in the first trimester and altered counterregulatory responses that may decrease hypoglycemia awareness 1, 2
- Patient and family education about prevention, recognition, and treatment is crucial
Diabetic ketoacidosis (DKA) risk: Pregnancy is a ketogenic state, and DKA can occur at lower blood glucose levels
Preeclampsia prevention: Prescribe low-dose aspirin (81 mg/day) from the end of the first trimester until delivery 1, 2
Blood pressure targets: 120-160/80-105 mmHg to optimize maternal health and minimize impaired fetal growth 1
Retinopathy monitoring: Rapid implementation of tight glycemic control can worsen retinopathy; regular eye exams are recommended each trimester 2
Role of Metformin
While insulin remains the preferred treatment, there is emerging evidence regarding metformin:
- Metformin crosses the placenta, with umbilical cord blood levels equal to or higher than maternal levels 1
- The MiTy trial showed that adding metformin to insulin in women with T2DM resulted in:
- Better glycemic control
- Less maternal weight gain
- Lower insulin requirements
- Fewer cesarean births
- However, metformin-exposed infants weighed less and had a higher proportion of small-for-gestational-age babies 3
Postpartum Considerations
- Insulin requirements drop dramatically after delivery of the placenta 1, 2
- Women become very insulin sensitive immediately postpartum and may require much less insulin than during pregnancy
- Return to pre-pregnancy insulin sensitivity occurs over 1-2 weeks 2
- Postpartum screening for persistent diabetes or prediabetes with a 75-g OGTT at 4-12 weeks 1
- Consider metformin for postpartum diabetes prevention in women with previous GDM 4
- Implement a contraceptive plan for all women with diabetes of reproductive potential 1
Pitfalls to Avoid
- Inadequate monitoring: Frequent blood glucose monitoring and insulin dose adjustments are essential throughout pregnancy due to changing insulin requirements
- Delayed recognition of DKA: Remember that DKA can occur at lower blood glucose levels during pregnancy
- Ignoring signs of placental insufficiency: A rapid reduction in insulin requirements in late pregnancy may indicate placental insufficiency and requires immediate evaluation
- Overlooking hypoglycemia risk: Especially in the first trimester and immediately postpartum
- Failing to adjust insulin doses postpartum: Insulin requirements decrease by approximately 34% compared to pre-pregnancy levels immediately after delivery 2
By following these guidelines, T2DM can be effectively managed during pregnancy to optimize outcomes for both mother and baby.